MedTrace Logo

High Resolution Diffusion Weighted Imaging in Prostate

NCT06636747 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2024-10-15

No results posted yet for this study

Summary

hrDWI might be an alternative to cDWI for the prostate imaging.

1. increase the signal-to-noise ratio and contrast-to-noise ratio, yielding high-fidelity images with less noise in general
2. improve the diagnostic accuracy of PCa in particular than conventional DWI

Conditions

Sponsors & Collaborators

  • The First Affiliated Hospital with Nanjing Medical University

    lead OTHER

Principal Investigators

  • Fei-Yun Wu · The First Affiliated Hospital with Nanjing Medical University

Eligibility

Min Age
55 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-01
Primary Completion
2025-07-31
Completion
2026-07-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06636747 on ClinicalTrials.gov